Please login to the form below
situximab
This page shows the latest situximab news and features for those working in and with pharma, biotech and healthcare.
EMA backs Janssen rare disease drug for approval
Castleman's disease treatment Sylvant wins CHMP recommendation. J&J subsidiary Janssen-Cilag's Castleman's disease treatment Sylvant (situximab) has been recommended for approval in Europe.
Latest news
-
Boehringer/Lilly's empagliflozin among CHMP recommendations
There were also recommendations for four orphan drugs: Janssen-Cilag's Sylvant (situximab) and, along with the companion diagnostic drugs Folcepri (etarfolatide) and Neocepri (folic acid), Endocyte's Vynfinit (vintafolide).
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Account Director – UK Office
-
Excellent salary and benefits
-
Account Director
-
£Competitive Salary
-
Account Manager (PR)
-
Great Benefits
-
Senior External Communications Lead
-
£Competitive Salary
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Account Manager
-
£Competitive Salary
-
Senior Account Manager
-
Salary TBC
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- FDA grants emergency authorisation to chloroquine for COVID-19
- AbbVie suspends Kaletra patent rights as COVID-19 drug trials advance
- Novartis donates malaria drug for COVID-19 clinical trials
- Moderna and GSK advance coronavirus vaccine candidates
- Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19
- Germany's coronavirus infections climb but deaths remain low
- OSE lung cancer vaccine clears phase 3 hurdle, but COVID-19 stalls programme
- Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in UK
- UK government reveals only 2,000 key NHS staff have been tested for coronavirus
- Today’s reality: how to make social distancing work in medcomms
- Q&A: Kate Paxton
- Lilly cuts deal with UK’s Sitryx for autoimmune disease drugs
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
Latest intelligence
- Delivering true value: what does it mean for KAM in cancer care?
- Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
- Pharma funding and M&A in 2020
- Why pharma M&A has continually bucked the trend...
- Behaviour change through medical education: How can we turn aspiration into reality?
- Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...
Quick links
Infographics
